SY

Sriharsha Yanamadala

Active Director Designated Partner DIN 11541780
DIN 11541780 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sriharsha Yanamadala

Data last updated:

Sriharsha Yanamadala is a Designated Partner at Q-Therapeutics Llp (since 2026).

DIN 11541780
Primary Designation Designated Partner
First Appointment 12 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Feb 20262026Active

Board colleagues of Sriharsha Yanamadala

NameDINCompanyDesignation
Gowtam Manne11541781Q-Therapeutics LlpDesignated Partner
Karthik Are10538676Q-Therapeutics LlpDesignated Partner
Siva Pradeep Yanamadala11541779Q-Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Q-Therapeutics Llp
Premium access

Shareholding and investment profile for Sriharsha Yanamadala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sriharsha Yanamadala

Sriharsha Yanamadala currently holds 1 directorship: Q-Therapeutics Llp (Designated Partner, since 12 Feb 2026).

Sriharsha Yanamadala was first appointed on 12 Feb 2026 as Designated Partner at Q-Therapeutics Llp.

The current boards of Sriharsha Yanamadala's companies include Gowtam Manne (Q-Therapeutics Llp), Karthik Are (Q-Therapeutics Llp), Siva Pradeep Yanamadala (Q-Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available